Here’s good news for those suffering from Parkinson’s disease. The FDA has given the green light to the Brio Neurostimulation System to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that tops the list as one of the most common causes of tremors.
The system consists of an implantable deep brain stimulation device that offers better results from symptoms such as tremors and problems in walking and balancing compared to sole medication.
William Maisel of the office of device evaluation at the FDA’s Center for Devices and Radiological Health, clarifies the limits of the said system and the status of Parkinson’s disease where cure is concerned: “There are no cures for Parkinson’s disease or essential tremor, but finding better ways to manage symptoms is essential for patients. “This new device adds to the array of treatment options to help people living with Parkinson’s and essential tremor enjoy better, more productive lives.”
The Brio Neurostimulation System is a tiny battery-powered rechargeable electrical pulse generator that is implanted under the skin of the upper chest. This revolutionary technology has wire leads that attach to electrodes placed within particular areas of the brain, the exact points determined by the patient’s specific treatment needs. It works by delivering “low intensity electrical pulses to target areas in the brain.”
In the two researches conducted to test the application which involve 136 Parkinson’s patients in the first study and 127 patients with essential tremor in the second, the device’s effectiveness in offering relief from the disease was confirmed. In fact, in both studies, the system, coupled with medication, helped control or improve the symptoms of Parkinson’s disease without the needs for further medications.
The Brio Neurostimulation System holds the record of being the second Parkinson’s disease relieving device next to Medtronic’s Activa Deep Brain Stimulation Therapy System (approved in 1997) to receive the FDA’s approval for Parkinson’s and essential tremor.
Source: Rephrased from source: http://www.pmlive.com/pharma_news/fda_approves_brain_implant_for_parkinsons_disease_758585